TABLE 3.
Pilot (N = 29) |
Replication (N = 50) |
||||
---|---|---|---|---|---|
Scale | Group | Mean (SD) | p Value | Mean (SD) | p Value |
Morphine Benzedrine group | Non-OUD | 0370 (0.28) | 0.005 | 0.293 (0.27) | <0.0001 |
OUD | 0.673 (0.21) | 0.624 (0.23) | |||
Pentobarbital chlorpromazine alcohol group | Non-OUD | 0.543 (0.28) | 0.82 | 0.448 (0.19) | 0.23 |
OUD | 0.593 (0.19) | 0.532 (0.29) | |||
Amphetamine group | Non-OUD | 0.232 (0.22) | 0.002 | 0.256 (0.21) | 0.0001 |
OUD | 0.558 (0.25) | 0.556 (0.26) | |||
Lysergic acid diethylamide group | Non-OUD | 0.318 (0.11) | 0.13 | 0.273 (0.17) | 0.034 |
OUD | 0.400 (0.15) | 0.407 (0.23) | |||
Benzedrine group | Non-OUD | 0.214 (0.19) | 0.022 | 0.310 (0.20) | 0.017 |
OUD | 0.422 (0.27) | 0.478 (0.26) |
Note: Items included in pilot and replication sample assessments–MBG 11/15; PCAG 10/15; AG 8/10; LSDG 9/12; BG 6/12; Mann–Whitney U tests were performed.